Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 2
1965 1
1966 2
1967 1
1968 1
1969 1
1970 3
1971 2
1972 1
1973 2
1974 7
1975 3
1976 8
1977 7
1978 7
1979 8
1980 5
1981 6
1982 11
1983 18
1984 8
1985 7
1986 12
1987 14
1988 17
1989 16
1990 21
1991 19
1992 26
1993 19
1994 21
1995 16
1996 24
1997 18
1998 21
1999 30
2000 17
2001 35
2002 32
2003 25
2004 36
2005 44
2006 34
2007 42
2008 36
2009 36
2010 27
2011 49
2012 49
2013 62
2014 106
2015 106
2016 107
2017 115
2018 104
2019 136
2020 134
2021 198
2022 181
2023 147
2024 64

Text availability

Article attribute

Article type

Publication date

Search Results

2,076 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
ANOCA/INOCA/MINOCA: Open artery ischemia.
Pepine CJ. Pepine CJ. Am Heart J Plus. 2023 Feb;26:100260. doi: 10.1016/j.ahjo.2023.100260. Epub 2023 Jan 25. Am Heart J Plus. 2023. PMID: 37064505 Free PMC article.
For over a century, the major clinical phenotype was taken to be obstructive atherosclerosis involving the larger coronary arteries (e.g., coronary artery disease [CAD]). However, evolving evidence now indicates that nonobstructive CAD is the predominant phenotype. ...
For over a century, the major clinical phenotype was taken to be obstructive atherosclerosis involving the larger coronary arteries (e.g …
Therapeutic potential of intermittent hypoxia: a matter of dose.
Navarrete-Opazo A, Mitchell GS. Navarrete-Opazo A, et al. Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1181-97. doi: 10.1152/ajpregu.00208.2014. Epub 2014 Sep 17. Am J Physiol Regul Integr Comp Physiol. 2014. PMID: 25231353 Free PMC article. Review.
To understand the impact of IH, it is essential to define critical characteristics of the IH protocol under investigation, including potentially the severity of hypoxia within episodes, the duration of hypoxic episodes, the number of hypoxic episodes per day, the pattern of prese …
To understand the impact of IH, it is essential to define critical characteristics of the IH protocol under investigation, including potenti …
Literature Commentary.
[No authors listed] [No authors listed] J Neuroophthalmol. 2019 Jun;39(2):273-278. doi: 10.1097/WNO.0000000000000789. J Neuroophthalmol. 2019. PMID: 31094997
J Neurosurg. 2018;129:1078-1084.2. Pagovich OE, Vo ML, Zhao ZZ, Petropoulos IN, Yuan M, Lertsuwanroj B, Ciralsky J, Lai E, Kiss S, D'Amico DJ, Mezey JG, Malik RA, Crystal RG. ...Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. …
J Neurosurg. 2018;129:1078-1084.2. Pagovich OE, Vo ML, Zhao ZZ, Petropoulos IN, Yuan M, Lertsuwanroj B, Ciralsky J, Lai E, Kis …
Dr G.B. Mitchell-Heggs.
Bettley FR. Bettley FR. Br J Dermatol. 1976 May;94(5):588. doi: 10.1111/j.1365-2133.1976.tb05152.x. Br J Dermatol. 1976. PMID: 773410 No abstract available.
Erratum for the Report "Worldwide evidence of a unimodal relationship between productivity and plant species richness," by Lauchlan H. Fraser, J. Pither, A. Jentsch, M. Sternberg, M. Zobel, D. Askarizadeh, S. Bartha, C. Beierkuhnlein, J. A. Bennett, A. Bittel, B. Boldgiv, I. I. Boldrini, E. Bork, L. Brown, M. Cabido, J. Cahill, C. N. Carlyle, G. Campetella, S. Chelli, O. Cohen, A.-M. Csergo, S. Diaz, L. Enrico, D. Ensing, A. Fidelis, J. D. Fridley, B. Foster, H. Garris, J. R. Goheen, H. A. L. Henry, M. Hohn, M. H. Jouri, J. Klironomos, K. Koorem, R. Lawrence-Lodge, R. Long, P. Manning, R. Mitchell, M. Moora, S. C. Muller, C. Nabinger, K. Naseri, G. E. Overbeck, T. M. Palmer, S. Parsons, M. Pesek, V. D. Pillar, R. M. Pringle, K. Roccaforte, A. Schmidt, Z. Shang, R. Stahlmann, G. C. Stotz, S. Sugiyama, S. Szentes, D. Thompson, R. Tungalag, S. Undrakhbold, M. van Rooyen, C. Wellstein, J. B. Wilson, T. Zupo.
[No authors listed] [No authors listed] Science. 2021 May 28;372(6545):eabj5097. doi: 10.1126/science.abj5097. Science. 2021. PMID: 34045328 No abstract available.
Re: Rano Matta, Christopher J.D. Wallis, Mitchell G. Goldenberg, et al. Variation and Trends in Antidepressant Prescribing for Men Undergoing Treatment for Nonmetastatic Prostate Cancer: A Population-based Cohort Study. Eur Urol 2019;75:3-7: Translational Potential of Dual Detection: Depression Diagnosis plus Sense of Coherence Determination in Prostate Cancer.
Vale S. Vale S. Eur Urol. 2019 Jun;75(6):e168-e169. doi: 10.1016/j.eururo.2019.01.043. Epub 2019 Feb 4. Eur Urol. 2019. PMID: 30732926 No abstract available.
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration.
Khachigian LM, Liew G, Teo KYC, Wong TY, Mitchell P. Khachigian LM, et al. J Transl Med. 2023 Feb 21;21(1):133. doi: 10.1186/s12967-023-03937-7. J Transl Med. 2023. PMID: 36810060 Free PMC article. Review.
Evidence is emerging that targeting VEGF-A alone, as most agents have done until recently, may be insufficient and agents that target multiple pathways (e.g., aflibercept, faricimab and others in development) may be more efficacious. ...
Evidence is emerging that targeting VEGF-A alone, as most agents have done until recently, may be insufficient and agents that target multip …
2,076 results